TNDM in the 13F filings
Tandem Diabetes Care Inc · CUSIP 875372203
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 17 Nov 2025
- latest of these filings; the earliest 31 Oct 2025
- Managers listing it
- 6
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 4 listed it in both
- Shares listed
- 5,271,407
- combined, among listed positions
- Reported value
- $64m
- combined, at the quarter end
Among the 95 comparable managers: 4 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing TNDM in Q3 2025
6 of 6 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Freestone Grove Partners LP | 1,870,307 | $23m | 0.17% | New | new | 14 Nov 2025 (the filing on sec.gov) |
| Baillie Gifford & Co | 1,120,595 | $14m | under 0.1% | Trimmed | -5,133 | 31 Oct 2025 (the filing on sec.gov) |
| Two Sigma Advisers LP | 970,883 | $12m | under 0.1% | Added | +82,800 | 14 Nov 2025 (the filing on sec.gov) |
| Acadian Asset Management LLC | 918,723 | $11m | under 0.1% | Added | n.a. | 13 Nov 2025 (the filing on sec.gov) |
| Moore Capital Management LP | 220,479 | $2.7m | under 0.1% | Added | +160,753 | 14 Nov 2025 (the filing on sec.gov) |
| PDT Partners LLC | 170,420 | $2.1m | 0.13% | Held | 0 | 17 Nov 2025 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Freestone Grove Partners LPnew position · 1,870,307 shares now+1,870,307
- Moore Capital Management LPexisting position · 220,479 shares now+160,753
- Two Sigma Advisers LPexisting position · 970,883 shares now+82,800
Reductions
- Baillie Gifford & Coexisting position · 1,120,595 shares now-5,133
New positions and exits
New (1)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2018 | 1 | $5.0m | n.a. | n.a. |
| Q2 2018 | 2 | $50m | n.a. | n.a. |
| Q3 2018 | 5 | $172m | n.a. | n.a. |
| Q4 2018 | 6 | $179m | n.a. | n.a. |
| Q1 2019 | 9 | $226m | n.a. | n.a. |
| Q2 2019 | 10 | $206m | n.a. | n.a. |
| Q3 2019 | 7 | $259m | n.a. | n.a. |
| Q4 2019 | 4 | $232m | n.a. | n.a. |
| Q1 2020 | 9 | $944m | n.a. | n.a. |
| Q2 2020 | 10 | $1.7bn | n.a. | n.a. |
| Q3 2020 | 13 | $1.7bn | n.a. | n.a. |
| Q4 2020 | 6 | $1.1bn | n.a. | n.a. |
| Q1 2021 | 9 | $943m | n.a. | n.a. |
| Q2 2021 | 10 | $1.1bn | n.a. | n.a. |
| Q3 2021 | 13 | $1.5bn | n.a. | n.a. |
| Q4 2021 | 16 | $1.9bn | n.a. | n.a. |
| Q1 2022 | 13 | $1.4bn | n.a. | n.a. |
| Q2 2022 | 10 | $740m | n.a. | n.a. |
| Q3 2022 | 8 | $748m | n.a. | n.a. |
| Q4 2022 | 11 | $836m | n.a. | n.a. |
| Q1 2023 | 10 | $411m | n.a. | n.a. |
| Q2 2023 | 9 | $306m | n.a. | n.a. |
| Q3 2023 | 6 | $256m | n.a. | n.a. |
| Q4 2023 | 8 | $388m | 2 | 6 |
| Q1 2024 | 9 | $426m | 4 | 5 |
| Q2 2024 | 7 | $332m | 3 | 3 |
| Q3 2024 | 7 | $295m | 2 | 5 |
| Q4 2024 | 10 | $188m | 7 | 2 |
| Q1 2025 | 4 | $44m | 1 | 2 |
| Q2 2025 | 7 | $74m | 5 | 1 |
| Q3 2025 | 6 | $64m | 4 | 1 |
| Q4 2025 | 5 | $81m | 13 | 19 |
| Q1 2026 | 5 | $69m | 16 | 15 |
| Q2 2026 | 6 | $73m | 18 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TNDM and LLY →TNDM and JNJ →TNDM and VRTX →Choose a stock to compare with TNDM →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TNDM, latest filings →Back to the 13F Explorer →